AXTI — AXT, Inc.

AXT Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $47.6 million, a record high, up 77% from Q1 2026 ($26.9 million) and 164% from Q2 2025 ($18 million).
• Gross Margin: Non-GAAP gross margin improved to 45.0%, up from 29.9% in Q1 2026 and 8.2% in Q2 2025. GAAP gross margin was 44.9%.
• Operating Expenses: Non-GAAP operating expenses were $10.2 million, compared to $8.6 million in Q1 2026 and $7.6 million in Q2 2025. GAAP operating expenses were $10.9 million.
• Net Profit: Non-GAAP net profit of $11.9 million ($0.19 per diluted share), compared to a loss of $585,000 in Q1 2026 and a loss of $6.4 million in Q2 2025. GAAP net profit was $11.1 million ($0.17 per diluted share).
• Cash Position: Cash and investments increased to $749 million, primarily due to a secondary public offering that raised approximately $632 million.

2. Strategic Updates and Business Highlights

• Indium Phosphide Revenue: Reached $30.7 million, driven by data center applications, marking the highest revenue for this product category in company history.
• Long-term Supply Agreements: Signed agreements with Casella and Coherent, which include significant prepayments totaling $47.7 million.
• Capacity Expansion: Plans to double indium phosphide capacity in 2026, with potential to triple by year-end. The company is also advancing towards 6-inch indium phosphide substrate production.
• Market Demand: Strong demand for indium phosphide is driven by the AI infrastructure buildout, particularly in optical connectivity for data centers.

3. Forward Guidance and Outlook

• Q3 Revenue Guidance: Approximately $66 million expected, with potential upside if additional permits are received.
• Profitability: Projected non-GAAP net income between $0.30 to $0.32 per share and GAAP net income between $0.29 to $0.31 per share.
• Long-term Outlook: Revenue opportunity for indium phosphide is expected to triple by the end of 2026, with continued strong growth anticipated into 2027.

4. Bad News, Challenges, or Points of Concern

• Permit Uncertainty: While there is increased regularity in obtaining export permits, the timing remains unpredictable, which could impact revenue recognition.
• Capacity Constraints: Demand is outpacing supply, leading to challenges in fulfilling orders and managing backlog effectively.
• Operating Expenses: Rising operating expenses could pressure margins if not managed alongside revenue growth.

5. Notable Q&A Insights

• Capacity Projections: Analysts inquired about capacity targets, confirming plans to reach approximately $60 million in quarterly indium phosphide capacity by year-end, with further doubling anticipated in 2027.
• Backlog Clarification: Management indicated that backlog is well over $100 million and continues to grow, with long-term supply agreements covering future demand.
• Market Dynamics: Discussions highlighted the coexistence of indium phosphide and VCSEL technologies, with a preference for indium phosphide due to its performance advantages in high-speed applications.
• Gross Margin Potential: Management expressed optimism about achieving gross margins that could start with a "5" due to improved product mix and increased volume.

This summary captures the key financial metrics, strategic initiatives, forward guidance, challenges, and insights from the Q&A session, providing a comprehensive overview of AXT's performance and outlook.